Reprint

Novel Molecules in Diabetes Melitus, Dyslipidemia and Cardiovascular Disease

Edited by
May 2023
152 pages
  • ISBN978-3-0365-7685-5 (Hardback)
  • ISBN978-3-0365-7684-8 (PDF)

This book is a reprint of the Special Issue Novel Molecules in Diabetes Melitus, Dyslipidemia and Cardiovascular Disease that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

The purpose of this reprint based on the Special issue "Molecules in Diabetes Melitus, Dyslipidemia and Cardiovascular Disease”, IJMS journal, MDPI, is to present the impact in clinical practice as well as in medical research of novel molecules that have been introduced in the treatment of diabetes mellitus, dyslipidemia, and cardiovascular disease.

Format
  • Hardback
License
© by the authors
Keywords
nicotinamide mononucleotide; retinal ischemia/reperfusion; oxidative stress; neuroprotection; inflammation; sacubitril/valsartan; mortality; morbidity; heart failure; ejection fraction; diabetes mellitus; α-glucosidase; abietane diterpenoids; levopimaric acid; quinopimaric acid; molecular docking; ADMET; PFK15 synthesis; sunitinib L-malate; HUVEC; angiogenesis; synergy; cardiovascular medicine; diabetes; hypertension; GIP; GLP-1; glucagon; incretins; LY3298176; meta-analysis; obesity; SUMMIT; SURMOUNT; SURPASS; SYNERGY; Tirzepatide; nicotinamide mononucleotide; oxidative stress; common carotid artery occlusion; retinal ischemia; neuroprotection; dyslipidemia; statin; children; adolescents; metabolic syndrome; liver; hsa-miR-193b-3p; peroxisome proliferator activated receptor gamma coactivator 1 alpha; lipid metabolism; n/a; empagliflozin; type 2 diabetes mellitus; obesity; leptin; lipid metabolism; sphingolipids; sphingomyelinase; vasorelaxation; endothelial nitric oxide synthase; type 2 diabetes; thromboxane prostanoid receptor